| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0077 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.033 |
0.9 |
| mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.0097 |
0.9 |
| mRNA |
PHA-665752 |
GDSC1000 |
pan-cancer |
AAC |
0.0096 |
0.9 |